INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 422m ago
HOUSE PTR21m ago
SEC 13F21m ago
ROBINHOOD CHAIN21m ago
Public company

CTNMContineum Therapeutics, Inc.

CIK 0001855175

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score9
Connections8with evidence

CTNM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
LL
Lyons-Williams LoriDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Lyons-Williams LoriDirector · Jun 26, 2026
  • ← Insider ofevidence
    Ware Olivia CDirector · Jun 26, 2026
  • ← Insider ofevidence
    Schimmelpennink Evert B.Director · Jun 26, 2026
9
WC
Ware Olivia CDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A
—
19.0K sh
Jun 26, 2026
Jun 26, 2026
traded Jun 26, 2026
+0d
SEC FORM 4

Evidence

9
MD
Miralles Gines DiegoDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

9
SB
Schimmelpennink Evert B.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

9
IA
Ignelzi Troy A.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

9
BR
Brady Todd R.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

9
BS
Boyce SarahDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

← Insider ofevidence
Miralles Gines Diego
Director · Jun 26, 2026
  • ← Insider ofevidence
    Brady Todd R.Director · Jun 26, 2026
  • ← Insider ofevidence
    Boyce SarahDirector · Jun 26, 2026
  • ← Insider ofevidence
    Ignelzi Troy A.Director · Jun 26, 2026